Xin Li

36PUBLICATIONS
27CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsTraditional Chinese medicine and treatmentsPacific Peoples health policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 01, 2026
Antidiabetic Drug Use and Expenditure Trends After National Volume-Based Procurement Policy in Nanjing City: An Interrupted Time-Series Analysis.

|Mar 16, 2026
Cadonilimab plus chemotherapy for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in China and the United States: a cost-effectiveness analysis.

Jia Wang, Baolong Ding, Zhuying Jing

|Feb 09, 2026
Impact of national volume-based procurement on physicians' antimicrobial prescribing behaviours: an interrupted time series analysis of 1200 prescriptions in a tertiary hospital.

Zhenzhen Du, Jiapei Yao, Xinru Liu

|Nov 27, 2025
Long-term cost-effectiveness of pharmacist-managed hypertension care in China.

Jingxuan Wei, Lihong Gao, Zhuying Jing

|Nov 21, 2025
Cost‑effectiveness analysis of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for gastric cancer in China.

Jun Shi, Yuyang Sun, Qiang Liu

|Nov 21, 2025
Parents' preference for the inclusion of pediatric vaccines in the Chinese National Immunization Program: A discrete choice experiment.

Xiaoye Wang, Yuyang Sun, Jia Wang

Pageof 6

Frequent Collaborators

6 joint publications

Yingtao Lin

3 joint publications

Lingli Zhang

3 joint publications

Yuyang Sun

2 joint publications

Jingxuan Wei